Furthermore, RIPK1 deficiency diminishes smoking-induced pulmonary cell apoptosis and necrotic cell death, thereby alleviating airway inflammation, remodeling, and emphysema [52] while also preventing cigarette-induced impairment of mucociliary clearance [53]. Here, RIPK1 is linked to pulmonary emphysema.